220 related articles for article (PubMed ID: 32331219)
1. Synthesis, Antitumor Evaluation, Molecular Modeling and Quantitative Structure-Activity Relationship (QSAR) of Novel 2-[(4-Amino-6-
Tomorowicz Ł; Sławiński J; Żołnowska B; Szafrański K; Kawiak A
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331219
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Molecular Structure, Anticancer Activity, and QSAR Study of
Żołnowska B; Sławiński J; Brzozowski Z; Kawiak A; Belka M; Zielińska J; Bączek T; Chojnacki J
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772699
[TBL] [Abstract][Full Text] [Related]
3. New 2-[(4-Amino-6-
Tomorowicz Ł; Żołnowska B; Szafrański K; Chojnacki J; Konopiński R; Grzybowska EA; Sławiński J; Kawiak A
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806186
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Molecular Structure, Metabolic Stability and QSAR Studies of a Novel Series of Anticancer N-Acylbenzenesulfonamides.
Żołnowska B; Sławiński J; Belka M; Bączek T; Kawiak A; Chojnacki J; Pogorzelska A; Szafrański K
Molecules; 2015 Oct; 20(10):19101-29. PubMed ID: 26506328
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (
Szafrański K; Sławiński J; Tomorowicz Ł; Kawiak A
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210190
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, QSAR studies, and metabolic stability of novel 2-alkylthio-4-chloro-N-(5-oxo-4,5-dihydro-1,2,4-triazin-3-yl)benzenesulfonamide derivatives as potential anticancer and apoptosis-inducing agents.
Żołnowska B; Sławiński J; Pogorzelska A; Szafrański K; Kawiak A; Stasiłojć G; Belka M; Zielińska J; Bączek T
Chem Biol Drug Des; 2017 Sep; 90(3):380-396. PubMed ID: 28122174
[TBL] [Abstract][Full Text] [Related]
7. Novel 5-Substituted 2-(Aylmethylthio)-4-chloro-N-(5-aryl-1,2,4-triazin-3-yl)benzenesulfonamides: Synthesis, Molecular Structure, Anticancer Activity, Apoptosis-Inducing Activity and Metabolic Stability.
Żołnowska B; Sławiński J; Pogorzelska A; Szafrański K; Kawiak A; Stasiłojć G; Belka M; Ulenberg S; Bączek T; Chojnacki J
Molecules; 2016 Jun; 21(6):. PubMed ID: 27338337
[TBL] [Abstract][Full Text] [Related]
8. Novel 2-benzylthio-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamides with anticancer activity: Synthesis, QSAR study, and metabolic stability.
Sławiński J; Szafrański K; Pogorzelska A; Żołnowska B; Kawiak A; Macur K; Belka M; Bączek T
Eur J Med Chem; 2017 May; 132():236-248. PubMed ID: 28364658
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro antitumor activity of novel series 2-benzylthio-4-chlorobenzenesulfonamide derivatives.
Sławiński J; Brzozowski Z
Eur J Med Chem; 2006 Oct; 41(10):1180-9. PubMed ID: 16777268
[TBL] [Abstract][Full Text] [Related]
10. Novel p-Functionalized Chromen-4-on-3-yl Chalcones Bearing Astonishing Boronic Acid Moiety as MDM2 Inhibitor: Synthesis, Cytotoxic Evaluation and Simulation Studies.
Bhatia RK; Singh L; Garg R; Kaur M; Yadav M; Madan J; Kancherla S; Pissurlenkar RRS; Coutinho EC
Med Chem; 2020; 16(2):212-228. PubMed ID: 31146672
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, biological evaluation, QSAR analysis and molecular modelling of new thiazol-benzimidazoles as EGFR inhibitors.
Srour AM; Ahmed NS; Abd El-Karim SS; Anwar MM; El-Hallouty SM
Bioorg Med Chem; 2020 Sep; 28(18):115657. PubMed ID: 32828424
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Antitumor Evaluation of Novel 5-Hydrosulfonyl-1H-benzo[d]imidazol-2(3H)-one Derivatives.
Ouyang G; Tong R; Li J; Bai L; Ouyang L; Duan X; Li F; He P; Shi J; He Y
Molecules; 2016 Apr; 21(4):516. PubMed ID: 27104509
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular structure, and in vitro antitumor activity of new 4-chloro-2-mercaptobenzenesulfonamide derivatives.
Sławiński J; Gdaniec M
Eur J Med Chem; 2005 Apr; 40(4):377-89. PubMed ID: 15804537
[TBL] [Abstract][Full Text] [Related]
14. Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies.
Eldehna WM; Abo-Ashour MF; Nocentini A; Gratteri P; Eissa IH; Fares M; Ismael OE; Ghabbour HA; Elaasser MM; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2017 Oct; 139():250-262. PubMed ID: 28802125
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis and Anticancer Profile of New 4-(1
Abdel-Maksoud MS; Mohamed AAB; Hassan RM; Abdelgawad MA; Chilingaryan G; Selim S; Abdel-Bakky MS; Al-Sanea MM
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638829
[TBL] [Abstract][Full Text] [Related]
16. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
Davis GD; Vasanthi AH
Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
[TBL] [Abstract][Full Text] [Related]
17. Novel thiazolidines: Synthesis, antiproliferative properties and 2D-QSAR studies.
Singh RP; Aziz MN; Gout D; Fayad W; El-Manawaty MA; Lovely CJ
Bioorg Med Chem; 2019 Oct; 27(20):115047. PubMed ID: 31471102
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Anti-Breast Cancer Activity, and Molecular Docking Study of a New Group of Acetylenic Quinolinesulfonamide Derivatives.
Marciniec K; Pawełczak B; Latocha M; Skrzypek L; Maciążek-Jurczyk M; Boryczka S
Molecules; 2017 Feb; 22(2):. PubMed ID: 28212337
[TBL] [Abstract][Full Text] [Related]
19. Comparative validated molecular modeling of p53-HDM2 inhibitors as antiproliferative agents.
Mondal C; Halder AK; Adhikari N; Saha A; Saha KD; Gayen S; Jha T
Eur J Med Chem; 2015 Jan; 90():860-75. PubMed ID: 25535952
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel quinazoline-sulfonamides as anti-cancer agents.
Poudapally S; Battu S; Velatooru LR; Bethu MS; Janapala VR; Sharma S; Sen S; Pottabathini N; Iska VBR; Katangoor V
Bioorg Med Chem Lett; 2017 May; 27(9):1923-1928. PubMed ID: 28351589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
